CALZF (Polynovo) Short-Term Debt: $1.86 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CALZF Polynovo Ltd CALZF
74 GF Score
Price $0.62
GF Value $2.23
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Polynovo Short-Term Debt?

Polynovo CALZF 74 Short-Term Debt is $1.86 Mil as of Dec. 2025. GuruFocus rates CALZF with a GF Score™ of 74/100 and a GF Value™ of $2.23 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Polynovo's Short-Term Debt for the quarter that ended in Dec. 2025 was $1.86 Mil.

Polynovo's quarterly Short-Term Debt declined from Dec. 2024 ($2.47 Mil) to Jun. 2025 ($0.97 Mil) but then increased from Jun. 2025 ($0.97 Mil) to Dec. 2025 ($1.86 Mil).

Polynovo's annual Short-Term Debt increased from Jun. 2023 ($0.94 Mil) to Jun. 2024 ($1.25 Mil) but then declined from Jun. 2024 ($1.25 Mil) to Jun. 2025 ($0.97 Mil).

Polynovo Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Polynovo Short-Term Debt Related Terms

Polynovo Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Polynovo's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polynovo Short-Term Debt Chart

Polynovo Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 0.94 0.94 1.25 0.97

Polynovo Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.25 2.47 0.97 1.86
CALZF
74GF Score
Polynovo Ltd CALZF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $1.86 Mil mean?
Polynovo (CALZF) has a Short-Term Debt of $1.86 Mil as of Dec. 2025.
Is Polynovo's Short-Term Debt too high?
Polynovo's current Short-Term Debt is $1.86 Mil. Overall, Polynovo has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Polynovo's Short-Term Debt compare to ABT and SYK?
Polynovo's Short-Term Debt of $1.86 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Polynovo's current Short-Term Debt is $1.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polynovo stock overvalued right now?
Based on GuruFocus' analysis, Polynovo (CALZF) is currently considered Significantly Undervalued. The stock's GF Value™ is $2.23, compared to a current price of $0.62 — trading 72.2% below its estimated fair value. The current Short-Term Debt is $1.86 Mil. Polynovo's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Polynovo (CALZF), the current Short-Term Debt is $1.86 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polynovo (CALZF) Overvalued in 2026?

Based on GuruFocus' analysis, Polynovo stock appears to be undervalued. The current stock price of $0.62 is trading 72.2% below its estimated GF Value™ of $2.23. GuruFocus considers Polynovo to be Significantly Undervalued.

Key valuation signals for CALZF:

  • Short-Term Debt: $1.86 Mil
  • GF Value™: $2.23 vs. price of $0.62 (72.2% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the CALZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polynovo Business Description

Other Exchanges MFJ:GermanyPNV:Australia
Address 320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
74GF Score

Get the complete analysis for CALZF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.62
Price
$2.23
GF Value